Id |
Subject |
Object |
Predicate |
Lexical cue |
T3 |
0-12 |
Sentence |
denotes |
Dear Editor: |
T4 |
13-61 |
Sentence |
denotes |
We appreciate the comment from Hemilä et al [1]. |
T5 |
62-201 |
Sentence |
denotes |
Previous studies based on in-vitro experiments have identified that high dosage intravenous Vit-C with copper and/or iron is virucidal [2]. |
T6 |
202-307 |
Sentence |
denotes |
However, despite these studies, the in-vivo virucidal activity of Vit-C has not been confirmed in detail. |
T7 |
308-447 |
Sentence |
denotes |
Previously, your meta-analyses of clinical trial data showed that regular Vit-C intake shortened the duration of the common cold by 8% [3]. |
T8 |
448-665 |
Sentence |
denotes |
However, coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus (severe acute respiratory syndrome coronavirus 2) whose genome sequence differs from other human coronaviruses causing the common cold [4]. |
T9 |
666-849 |
Sentence |
denotes |
Moreover, two recent clinical trials have demonstrated no significant difference in the development of sepsis, or severe acute respiratory failure, between Vit-C and non-Vit-C groups. |
T10 |
850-1019 |
Sentence |
denotes |
In the CITRIS-ALI trial, no significant difference was found between the Vit-C (50 mg/kg every 6 hours for 96 hours) and placebo groups in the primary outcomes measured. |
T11 |
1020-1153 |
Sentence |
denotes |
These included modified Sequential Organ Failure Assessment score, C-reactive protein levels, and thrombomodulin levels at 168 hours. |
T12 |
1154-1379 |
Sentence |
denotes |
However, secondary outcome measures did differ between the groups with 28-day all-cause mortality significantly lower and intensive care unit-free days significantly shorter in the placebo groups than in the Vit-C groups [5]. |
T13 |
1380-1798 |
Sentence |
denotes |
The Vitamin C, hydrocortisone and thiamine in patients with septic shock (VITAMINS) trial also reported that among patients with septic shock, a combination of intravenous Vit-C, hydrocortisone, and thiamine did not significantly improve the primary outcome measure (duration of time alive and free of vasopressor administration over 7 days) compared with that after the intravenous hydrocortisone treatment alone [6]. |
T14 |
1799-1968 |
Sentence |
denotes |
Although Vit-C generally exhibits low toxicity, taking >2 g of Vit-C per day may cause adverse gastrointestinal events including abdominal pain, diarrhea, and/or nausea. |
T15 |
1969-2102 |
Sentence |
denotes |
Although Vit-C is a water-soluble vitamin, with excess excreted in the urine, it can contribute to the formation of renal stones [7]. |
T16 |
2103-2299 |
Sentence |
denotes |
Additionally, glucose-6-phosphate dehydrogenase (G6PD) deficiency, a genetic condition that results in inadequate G6PD levels, can cause hemolytic anemia following intravenous Vit-C treatment [8]. |
T17 |
2300-2406 |
Sentence |
denotes |
Currently, multiple clinical trials investigating the effect of Vit-C on severe COVID-19 are on going [9]. |
T18 |
2407-2557 |
Sentence |
denotes |
However, this therapy can only be considered, and therefore incorporated into treatment guidelines, based on sufficient confirmatory research results. |
T19 |
2558-2588 |
Sentence |
denotes |
For now, we will have to wait. |